Understanding ACR and Urine Albumin: What the Test Tells You

The urine albumin-to-creatinine ratio, usually written uACR or ACR, measures two things in one urine sample: albumin and creatinine. Albumin is a specific protein that should mostly stay in your blood; creatinine is a normal waste product that leaves the body in urine. The lab divides the albumin result by the creatinine result to get a ratio. NIDDK explains how the ratio is calculated.

Because creatinine leaves the body at a steady rate, the ratio stays fairly constant even when your urine is concentrated or diluted. That makes a single sample usable; you usually do not need to collect urine for 24 hours. The National Kidney Foundation describes why a spot sample works.

The result is reported in two unit systems. In the United States it is usually mg/g; in many other countries it is mg/mmol. The numbers are different, so always check which unit your lab used before comparing results. The result is not a symptom score and not a measure of how much fluid you drank.

The estimated glomerular filtration rate, or eGFR is the other main CKD marker. uACR looks at whether albumin is leaking into urine; eGFR estimates how well the kidneys filter blood. Your clinician reads the two together.

Some lab reports also show total urine protein or a urine protein-to-creatinine ratio. Those tests count many proteins at once. KDIGO recommends focusing on albumin, because albumin is the predominant urinary protein in many common glomerular diseases and the test is sensitive at low levels. Other tests may be needed when non-albumin proteinuria, including tubular or light-chain proteinuria, is suspected. If your report shows both numbers, ask which one your clinician is following.

Albumin in the urine exists on a scale; there is no single "fine" number. KDIGO groups results into three categories:

• A1: below 30 mg/g (below 3 mg/mmol) — normal to mildly increased.

• A2: 30–300 mg/g (3–30 mg/mmol) — moderately increased.

• A3: above 300 mg/g (above 30 mg/mmol) — severely increased.

A lower number is better. But the category is only one input; the number also has to be read with your eGFR, your medical history, and how the result changes over time. The National Kidney Foundation walks through what each range means and what follow-up usually looks like.

Two older labels still float around on reports and websites. "Microalbuminuria" is the old name for the A2 range, and "macroalbuminuria" is the old name for A3. NIDDK notes that the 300 mg/g cut-off only reflects how sensitive old dipsticks were; it is not a sharp biological boundary. Current guidelines prefer the A1–A3 names.

For a CKD diagnosis, the marker has to persist. KDIGO defines CKD as abnormalities present for at least three months. A single raised uACR is a signal to look closer, not a final verdict. Similarly, NICE guidance says a result between 3 and 70 mg/mmol should be confirmed on a later early-morning sample, while a result of 70 mg/mmol (about 620 mg/g) or more does not need that confirmation step.

So: a uACR of 30 mg/g or higher in a one-off sample does not automatically mean you have chronic kidney disease. Persistent albuminuria does. Your clinician decides what counts as confirmation in your situation.

uACR can swing from day to day. KDIGO lists the factors that can push a result up or down:

• Vigorous exercise in the 24 hours before the sample can raise albumin.

• Fever, infection, or a urinary tract infection can raise it.

• Very concentrated urine can change the number even when the ratio is doing its job.

• Dehydration, menstruation, and blood in the urine can also affect it.

The biological variation in urine albumin is large — the guideline notes it exceeds 60% — which is why a single number rarely stands alone. NIDDK recommends repeat testing after exercise, fever, or infection settle.

That cuts both ways. A high number does not mean you should ignore it; it means the number needs context. A normal result during a fever is reassuring but still worth repeating at a calmer moment if your clinician recommends it.

The big picture matters more than one sample: eGFR, blood pressure, diabetes control if you have diabetes, medicines, and the trend in your urine results over months.

The uACR is part of routine screening for people at higher risk of kidney disease. NICE lists the groups to test: people with diabetes, high blood pressure, cardiovascular disease, a previous acute kidney injury, or a family history of kidney disease, among others. NIDDK recommends checking urine albumin yearly in people with type 2 diabetes or long-standing type 1 diabetes.

How often you repeat it depends on your results and your eGFR. Someone in the A1 range may be tested yearly; someone in A2 or A3 is usually tested more often so your team can see whether treatment is working. NIDDK describes reducing urine albumin toward the normal range as a treatment goal in many people.

It is not a test you need to prepare for in a complicated way, but a few habits make the result cleaner. Avoid intense exercise in the 24 hours before the sample. If you have a fever, an infection, or your period, tell your clinician; the sample can usually wait a few days or be repeated.

You do not need a 24-hour collection for routine care. The ratio from a single sample estimates your daily albumin loss closely enough for screening and monitoring.

Albuminuria is not a disease you treat with one switch; it is a signal your care team uses to pick the right combination. The mainstays are:

• Blood pressure control, often with ACE inhibitors or ARBs. These two medicine classes lower blood pressure and also reduce albumin loss. They are chosen when appropriate — not for everyone, and your clinician decides based on your labs and health. They can raise potassium, so blood tests follow.

• Blood sugar control for people with diabetes.

• SGLT2 inhibitors for suitable people with CKD, including many people with albuminuria, as part of an individualized plan. They are prescribed, not self-started.

• Reducing cardiovascular risk: cholesterol management, stopping smoking, and keeping active as your clinician advises.

Two cautions. NSAIDs such as ibuprofen and naproxen can harm the kidneys with regular use and are usually worth avoiding or checking before taking. And do not stop or change any prescribed medicine unless your clinician tells you to — ACE inhibitors and ARBs are usually protecting your kidneys even though the creatinine number can shift when they start.

Most albuminuria causes no symptoms at all. That is the point of the test. But kidney problems can occasionally show themselves quickly, and those signs need action.

Call your clinician or clinic the same day

• New visible blood in your urine, or urine that turns cola-colored or very dark.

• Swelling that appears suddenly or quickly gets worse in your legs, ankles, hands, or face, or rapid weight gain over a day or two.

• Noticeably less urine than usual.

• Pain in your side or back with fever or chills — possible kidney infection.

• Vomiting or diarrhea that keeps you from keeping fluids down, especially if you have diabetes or take certain blood pressure medicines.

What can usually wait for a planned visit

A mildly changed uACR with no other symptoms, occasional foamy urine on its own, or a question about your results can usually wait for your next appointment. If the foam becomes persistent or marked, contact your clinic for advice; call the same day if it appears with new or worsening swelling, rapid weight gain, or noticeably less urine. Bring the lab report. If a symptom gets worse or something new appears, call sooner rather than guessing.

When in doubt, call your clinic. Your team would rather answer a quick question than hear about a problem late.

Bring these to your next appointment and write down the answers:

• What was my uACR, and which unit did the lab use — mg/g or mg/mmol?

• How does it compare with my last urine result, and is the change real?

• Do I need a repeat sample, and should it be a first-morning sample?

• Which medicines of mine help reduce albumin loss, and which should I avoid or check first?

• How often should this test be repeated, and what results would change the plan?

• What symptoms should make me call right away?

If your clinician suggests changes to sodium or potassium, the guides on sodium and CKD and potassium and CKD can help you prepare better questions. They are question lists, not personal prescriptions.